Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Lynda Diane Roman, MD

    TitleAssociate Professor of Obstetrics & Gynecology
    SchoolKeck School of Medicine of USC
    DepartmentObstetrics & Gynecology
    AddressIRD 520 2020 Zonal Ave
    Off Campus
    Los Angeles California 90033
    Phone+1 323 409 3405
    vCardDownload vCard
      Other Positions
      TitleDivision Chief, Gynecologic Oncology

      TitleDirector, Gynecology Oncology Fellowship


      Collapse Overview 
      Collapse Overview
      Dr. Roman completed her fellowship in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas in 1991. Presently, she serves as Director of the Division of Gynecologic Oncology at the University of Southern California, as well as the Director of Research and the Fellowship Program Director. Also, Dr. Roman is the co-director of the Lynne Cohen Preventive Cancer Care Clinic at the USC/Norris Cancer Center. she has recently been appointed to the governing council of the Society of Gynecologic Oncologists.


      Collapse Biography 
      Collapse Clinical Trials

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Matsuo K, Roman L, Wright JD. Reply. Am J Obstet Gynecol. 2017 Oct 20. PMID: 29061361.
        View in: PubMed
      2. Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura M, Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MMK, Ueland FR, Kelley JL, Roman L. Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma. Gynecol Oncol. 2017 Oct 19. PMID: 29056442.
        View in: PubMed
      3. Matsuo K, Johnson MS, Im DD, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Klobocista MM, Hasegawa K, Ueda Y, Shida M, Baba T, Satoh S, Yokoyama T, Machida H, Ikeda Y, Adachi S, Miyake TM, Iwasaki K, Yanai S, Takeuchi S, Nishimura M, Nagano T, Takekuma M, Shahzad MMK, Pejovic T, Omatsu K, Kelley JL, Ueland FR, Roman L. Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgery. J Surg Oncol. 2017 Oct 16. PMID: 29044542.
        View in: PubMed
      4. Matsuo K, Machida H, Frimer M, Marcus JZ, Pejovic T, Roman L, Wright JD. Prognosis of women with stage I endometrioid endometrial cancer and synchronous stage I endometrioid ovarian cancer. Gynecol Oncol. 2017 Oct 03. PMID: 28986093.
        View in: PubMed
      5. Machida H, Eckhardt SE, Castaneda AV, Blake EA, Pham HQ, Roman L, Matsuo K. Single Marital Status and Infectious Mortality in Women With Cervical Cancer in the United States. Int J Gynecol Cancer. 2017 Oct; 27(8):1737-1746. PMID: 28704326.
        View in: PubMed
      6. Matsuo K, Purushotham S, Moeini A, Li G, Machida H, Liu Y, Roman L. A pilot study in using deep learning to predict limited life expectancy in women with recurrent cervical cancer. Am J Obstet Gynecol. 2017 Aug 24. PMID: 28843741.
        View in: PubMed
      7. Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman L, Sood AK, Gershenson DM. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2017 Aug 08. PMID: 28787528.
        View in: PubMed
      8. Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman L, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol. 2017 Aug; 130(2):403-410. PMID: 28697110.
        View in: PubMed
      9. Matsuo K, Machida H, Horowitz MP, Shahzad MMK, Guntupalli SR, Roman L, Wright JD. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer. Am J Obstet Gynecol. 2017 Jun 27. PMID: 28666700.
        View in: PubMed
      10. Matsuo K, Machida H, Ragab OM, Garcia-Sayre J, Yessaian AA, Roman L. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer. J Surg Oncol. 2017 Sep; 116(4):482-491. PMID: 28543055.
        View in: PubMed
      11. Machida H, Maeda M, Cahoon SS, Scannell CA, Garcia-Sayre J, Roman L, Matsuo K. Endometrial cancer arising in adenomyosis versus endometrial cancer coexisting with adenomyosis: are these two different entities? Arch Gynecol Obstet. 2017 Jun; 295(6):1459-1468. PMID: 28444512.
        View in: PubMed
      12. Matsuo K, Machida H, Blake EA, Takiuchi T, Mikami M, Roman L. Significance of uterine corpus tumor invasion in early-stage cervical cancer. Eur J Surg Oncol. 2017 Apr; 43(4):725-734. PMID: 28215507.
        View in: PubMed
      13. Matsuo K, Machida H, Takiuchi T, Grubbs BH, Roman L, Sood AK, Gershenson DM. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. Gynecol Oncol. 2017 Mar; 144(3):496-502. PMID: 28131526.
        View in: PubMed
      14. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2017 Jan; 129(1):139-151. PMID: 27926642.
        View in: PubMed
      15. Matsuo K, Machida H, Ragab OM, Takiuchi T, Pham HQ, Roman L. Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer. Gynecol Oncol. 2017 Mar; 144(3):515-523. PMID: 28017306.
        View in: PubMed
      16. Matsuo K, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Ueda Y, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Takeuchi S, Nishimura M, Iwasaki K, Yanai S, Klobocista MM, Johnson MS, Machida H, Hasegawa K, Miyake TM, Nagano T, Pejovic T, Shahzad MM, Im DD, Omatsu K, Ueland FR, Kelley JL, Roman L. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma. Gynecol Oncol. 2017 Feb; 144(2):329-335. PMID: 27931750.
        View in: PubMed
      17. Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG. Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Dec; 143(3):650-654. PMID: 27771165.
        View in: PubMed
      18. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer. Obstet Gynecol. 2016 Oct; 128(4):761-70. PMID: 27607873.
        View in: PubMed
      19. Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer. 2016 Dec 15; 139(12):2646-2654. PMID: 27420401.
        View in: PubMed
      20. Matsuo K, Cahoon SS, Yoshihara K, Shida M, Kakuda M, Adachi S, Moeini A, Machida H, Garcia-Sayre J, Ueda Y, Enomoto T, Mikami M, Roman L, Sood AK. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer. Obstet Gynecol. 2016 Jul; 128(1):127-37. PMID: 27275802.
        View in: PubMed
      21. Matsuo K, Moeini A, Machida H, Fullerton ME, Shabalova A, Brunette LL, Roman L. Significance of venous thromboembolism in women with cervical cancer. Gynecol Oncol. 2016 Sep; 142(3):405-12. PMID: 27350404.
        View in: PubMed
      22. Lee AW, Ness RB, Roman L, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol. 2016 May; 127(5):828-36. PMID: 27054934; PMCID: PMC4892111 [Available on 05/01/17].
      23. Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, Hasegawa K, Shoupe D, Roman L. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2016 May; 23(5):535-43. PMID: 26757269.
        View in: PubMed
      24. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman L. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol. 2016 Jul; 27(7):1257-66. PMID: 27052653.
        View in: PubMed
      25. Matsuo K, Jung CE, Hom MS, Gualtieri MR, Randazzo SC, Kanao H, Yessaian AA, Roman L. Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2016 Feb; 26(2):290-300. PMID: 26569058.
        View in: PubMed
      26. Matsuo K, Gualtieri MR, Cahoon SS, Jung CE, Paulson RJ, Shoupe D, Muderspach LI, Wakatsuki A, Wright JD, Roman L. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2016 Feb; 23(2):189-96. PMID: 26173075.
        View in: PubMed
      27. Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, Adachi S, Garcia-Sayre J, Ueda Y, Roman L. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis. Ann Surg Oncol. 2016 Mar; 23(3):959-67. PMID: 26542589.
        View in: PubMed
      28. Machida H, Casey JP, Garcia-Sayre J, Jung CE, Casabar JK, Moeini A, Kato K, Roman L, Matsuo K. Timing of Intrauterine Manipulator Insertion During Minimally Invasive Surgical Staging and Results of Pelvic Cytology in Endometrial Cancer. J Minim Invasive Gynecol. 2016 Feb 01; 23(2):234-41. PMID: 26475765.
        View in: PubMed
      29. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman L. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol. 2015 Nov; 112(6):669-76. PMID: 26391212.
        View in: PubMed
      30. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman L, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Kast WM. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin Immunol. 2015 Dec; 161(2):197-208. PMID: 26360252; PMCID: PMC4658296 [Available on 12/01/16].
      31. Matsuo K, Ramzan AA, Gualtieri MR, Mhawech-Fauceglia P, Machida H, Moeini A, Dancz CE, Ueda Y, Roman L. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015 Nov; 139(2):261-7. PMID: 26238457.
        View in: PubMed
      32. Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman L, Gabra H, Fotopoulou C, Sood AK. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. Eur J Cancer. 2015 Sep; 51(14):1978-88. PMID: 26238017.
        View in: PubMed
      33. Machida H, Moeini A, Roman L, Matsuo K. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol. 2015 Oct; 139(1):165-71. PMID: 26193428.
        View in: PubMed
      34. Lawrenson K, Pakzamir E, Liu B, Lee JM, Delgado MK, Duncan K, Gayther SA, Liu S, Roman L, Mhawech-Fauceglia P. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium. PLoS One. 2015; 10(7):e0130909. PMID: 26132201; PMCID: PMC4488511.
      35. Matsuo K, Tierney KE, Schneider DM, Mhawech-Fauceglia P, Roman L, Gershenson DM. Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series. Gynecol Oncol Rep. 2015 Aug; 13:36-9. PMID: 26425718; PMCID: PMC4563586.
      36. Matsuo K, Opper NR, Roman L. In reply. Obstet Gynecol. 2015 Jun; 125(6):1498. PMID: 26000531.
        View in: PubMed
      37. Matsuo K, Hom MS, Moeini A, Machida H, Takeshima N, Roman L, Sood AK. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Gynecol Oncol. 2015 Aug; 138(2):332-8. PMID: 26013698.
        View in: PubMed
      38. Ravaud A, Barrios CH, Alekseev B, Tay MH, Agarwala SS, Yalcin S, Lin CC, Roman L, Shkolnik M, Anak O, Gogov S, Pelov D, Louveau AL, Melichar B. RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon a-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol. 2015 Jul; 26(7):1378-84. PMID: 25851632.
        View in: PubMed
      39. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman L. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015 Feb; 125(2):424-33. PMID: 25569000.
        View in: PubMed
      40. Pearce CL, Stram DO, Ness RB, Stram DA, Roman L, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, Wu AH, Berchuck A, Pike MC, Pharoah PDP. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2015 Apr; 24(4):671-676. PMID: 25623732; PMCID: PMC4892114.
      41. Wu E, Rogers A, Ji L, Sposto R, Church T, Roman L, Tripathy D, Lin YG. Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract. 2015 Mar; 11(2):e163-9. PMID: 25604595; PMCID: PMC4371122.
      42. Shostka KG, Pavlenko AN, Fedchenko AV, Fokina AV, Sakharov AA, Roman L. [OUTCOME OF PELVIC EXENTERATION FOR LOCALLY ADVANCED CANCER OF THE PELVIC ORGANS]. Vopr Onkol. 2015; 61(3):448-51. PMID: 26242160.
        View in: PubMed
      43. Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman L, Sood AK. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. Gynecol Oncol. 2015 Feb; 136(2):198-204. PMID: 25497604.
        View in: PubMed
      44. Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. PMID: 25374407.
        View in: PubMed
      45. Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman L. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Ann Surg Oncol. 2014 Dec; 21(13):4246-55. PMID: 25001096.
        View in: PubMed
      46. Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman L, Sood AK. Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer. Obstet Gynecol. 2014 May; 123(5):957-65. PMID: 24785846; PMCID: PMC4174541.
      47. Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman L, Sood AK. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Gynecol Oncol. 2014 Jun; 133(3):473-9. PMID: 24674832; PMCID: PMC4170217.
      48. Lentz SE, Tierney KE, Weaver FA, Roman L. Abdominal aortic resection and Y-graft placement to achieve complete cytoreduction in stage IIIc ovarian carcinoma. Obstet Gynecol. 2014 Feb; 123(2 Pt 2 Suppl 2):486-8. PMID: 24413236.
        View in: PubMed
      49. Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman L, Einstein MH, Drake RD, Childs BH. A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecol Oncol. 2014 Mar; 132(3):517-25. PMID: 24476788.
        View in: PubMed
      50. Baselga J, Manikhas A, Cortés J, Llombart A, Roman L, Semiglazov VF, Byakhov M, Lokanatha D, Forenza S, Goldfarb RH, Matera J, Azarnia N, Hudis CA, Rozencweig M. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol. 2014 Mar; 25(3):592-8. PMID: 24401928; PMCID: PMC4433508.
      51. Shostka KG, Pavlenko AN, Fokina AV, Kashina NO, Roman L. [Immediate and long-term results of treatment after pelvic exenteration for locally advanced cervical cancer]. Vopr Onkol. 2014; 60(3):319-22. PMID: 25033683.
        View in: PubMed
      52. Karpenko AV, Sibgatullin RR, Belova EN, Boiko AA, Zolotykh VG, Roman L. [Results of surgical treatment of oral cavity cancer T1-2N0M0]. Vestn Khir Im I I Grek. 2014; 173(2):52-6. PMID: 25055535.
        View in: PubMed
      53. Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, Tian Y, Sidhu R. Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. Ann Oncol. 2014 Jan; 25(1):107-16. PMID: 24356622.
        View in: PubMed
      54. Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman L. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014 Apr; 210(4):366.e1-366.e5. PMID: 24370689.
        View in: PubMed
      55. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecol Oncol. 2013 Oct; 131(1):109-12. PMID: 23917081.
        View in: PubMed
      56. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. PMID: 23718934.
        View in: PubMed
      57. Wolpin BM, O'Reilly EM, Ko YJ, Blaszkowsky LS, Rarick M, Rocha-Lima CM, Ritch P, Chan E, Spratlin J, Macarulla T, McWhirter E, Pezet D, Lichinitser M, Roman L, Hartford A, Morrison K, Jackson L, Vincent M, Reyno L, Hidalgo M. Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Ann Oncol. 2013 Jul; 24(7):1792-801. PMID: 23448807; PMCID: PMC3716216.
      58. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman L. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. PMID: 23262205.
        View in: PubMed
      59. Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman L. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012 Oct; 1(2):156-64. PMID: 23342265; PMCID: PMC3544453.
      60. Matsuo K, Fleischman F, Ghattas CS, Gabrielyan AS, Ballard CA, Roman L, Morrow CP. Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal vein. Fertil Steril. 2012 Nov; 98(5):1341-5.e1. PMID: 22902061.
        View in: PubMed
      61. Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. Phase II study of gemcitabine and docetaxel in recurrent platinum resistant ovarian cancer. Cancer Invest. 2012 May; 30(4):295-9. PMID: 22468744.
        View in: PubMed
      62. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman L. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. PMID: 22228425.
        View in: PubMed
      63. Roman L, Kostiuk IP, Shostka KG, Pavlenko AN, Krest'ianinov SS, Vasil'ev LA. [Pelvic exenteration in surgery for colorectal cancer]. Vopr Onkol. 2012; 58(3):363-8. PMID: 22888652.
        View in: PubMed
      64. Matsuo K, Blake EA, Yessaian AA, Roman L. Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer. Oncologist. 2012; 17(12):1598-9. PMID: 23263923; PMCID: PMC3528394.
      65. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman L, Berchuck A, Pearce CL, Laird PW. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011; 6(12):e28141. PMID: 22163280; PMCID: PMC3233546.
      66. Karachun AM, Sinenchenko GI, Roman L, Samsonov DV, Luft AV, Voshchinin EV. [Characteristics of tumor growth in patients with locally-advanced gastric cancer]. Vopr Onkol. 2011; 57(3):370-2. PMID: 21882610.
        View in: PubMed
      67. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman L, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7. PMID: 20966701.
        View in: PubMed
      68. Matsuo K, Lin YG, Roman L, Sood AK. Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs. 2010 Nov; 19(11):1339-54. PMID: 20815774; PMCID: PMC2962713.
      69. O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol. 2010 Aug; 21(8):1712-7. PMID: 20147741.
        View in: PubMed
      70. Karachun AM, Sinenchenko GI, Roman L, Samsonov DV, Luft AV. [Outcomes of surgical treatment for locally advanced gastric cancer]. Vopr Onkol. 2010; 56(1):24-8. PMID: 20361611.
        View in: PubMed
      71. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman L. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009 Mar 01; 27(7):1069-74. PMID: 19139430; PMCID: PMC2667811.
      72. Roman L, Kotiv BN, Bisenkov LN, Shostka KG, Kostiuk IP. [Palliative resection in esophageal cancer]. Vopr Onkol. 2009; 55(1):56-9. PMID: 19435201.
        View in: PubMed
      73. Trishikina EA, Orlova RV, Roman L. [Quality of life of patients with breast cancer receiving hormonal therapy, depending on age and marital status]. Vopr Onkol. 2009; 55(3):310-3. PMID: 19670730.
        View in: PubMed
      74. Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res. 2008 Nov 15; 14(22):7554-63. PMID: 19010874; PMCID: PMC2586993.
      75. Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM. Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008 Jan 01; 26(1):76-82. PMID: 18165643.
        View in: PubMed
      76. Garcia AA, Blessing JA, Vaccarello L, Roman L. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Am J Clin Oncol. 2007 Aug; 30(4):428-31. PMID: 17762444.
        View in: PubMed
      77. Roman L, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2007 Sep; 106(3):558-66. PMID: 17631950.
        View in: PubMed
      78. Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman L, Weber JS, Kast WM. Therapeutic vaccination for HPV induced cervical cancers. Dis Markers. 2007; 23(4):337-52. PMID: 17627067; PMCID: PMC3851105.
      79. Lowe MP, Bahador A, Muderspach LI, Burnett A, Santos L, Caffrey A, Roman L, Morrow CP. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program. J Minim Invasive Gynecol. 2006 Sep-Oct; 13(5):391-7. PMID: 16962520.
        View in: PubMed
      80. Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10; 24(26):4324-32. PMID: 16896006.
        View in: PubMed
      81. Amezcua CA, MacDonald HR, Lum CA, Yi W, Muderspach LI, Roman L, Felix JC. Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1336-41. PMID: 16803526.
        View in: PubMed
      82. Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman L. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006 Feb; 100(2):288-93. PMID: 16182347.
        View in: PubMed
      83. Roman L. Pregnancy after radical vaginal trachelectomy: maybe not such a risky undertaking after all. Gynecol Oncol. 2005 Jul; 98(1):1-2. PMID: 15946730.
        View in: PubMed
      84. Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol. 2005 Apr; 97(1):266-70. PMID: 15790474.
        View in: PubMed
      85. Brinkman JA, Caffrey AS, Muderspach LI, Roman L, Kast WM. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. Eur J Gynaecol Oncol. 2005; 26(2):129-42. PMID: 15857016.
        View in: PubMed
      86. Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. PMID: 16377584.
        View in: PubMed
      87. Perego C, Roman L, Chase F, Tegtmeier B. Algorithm guides ICP infection investigation. Hosp Case Manag. 2004 Nov; 12(11):167-8. PMID: 15540615.
        View in: PubMed
      88. Burnett AF, O'Meara AT, Bahador A, Roman L, Morrow CP. Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience. Gynecol Oncol. 2004 Oct; 95(1):189-92. PMID: 15385130.
        View in: PubMed
      89. Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. PMID: 15099968.
        View in: PubMed
      90. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman L, Yu MC, Zempolich K, Dubeau L. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res. 2004 Apr 15; 10(8):2681-6. PMID: 15102671.
        View in: PubMed
      91. Roman L, Fedorov KA, Krasnozhon DA. [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)]. Vopr Onkol. 2004; 50(1):99-100. PMID: 15088531.
        View in: PubMed
      92. Burnett AF, Roman L, O'Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol. 2003 Mar; 88(3):419-23. PMID: 12648596.
        View in: PubMed
      93. Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman L, Morrow CP, Burnett A, Muggia FM. Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome. Cancer. 2001 Jan 01; 91(1):90-100. PMID: 11148564.
        View in: PubMed
      94. Burnett AF, Coe FL, Klement V, O'Meara AT, Muderspach LI, Roman L, Morrow CP. The use of a pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy. Gynecol Oncol. 2000 Dec; 79(3):438-43. PMID: 11104616.
        View in: PubMed
      95. Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res. 2000 Sep; 6(9):3406-16. PMID: 10999722.
        View in: PubMed
      96. Israel VP, Garcia AA, Roman L, Muderspach L, Burnett A, Jeffers S, Muggia FM. Phase II study of liposomal doxorubicin in advanced gynecologic cancers. Gynecol Oncol. 2000 Aug; 78(2):143-7. PMID: 10926793.
        View in: PubMed
      97. Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology. 2000 Jul; 119(1):172-80. PMID: 10889166.
        View in: PubMed
      98. Stoiko IuM, Roman L, Karachun AM. [Ulcerated forms of gastric cancer as a clinical problem]. Vestn Khir Im I I Grek. 2000; 159(5):110-3. PMID: 11188807.
        View in: PubMed
      99. Miroshnikov BI, Pavelets KV, Marochkin NE, Roman L, Shostka KG, Shiriaev IuN. [Long-term outcome of surgical treatment of patients with esophageal cancer]. Vestn Khir Im I I Grek. 2000; 159(4):33-6. PMID: 11011399.
        View in: PubMed
      100. Burnett AF, Roman L, Garcia AA, Muderspach LI, Brader KR, Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2000 Jan; 76(1):63-6. PMID: 10620443.
        View in: PubMed
      101. Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, Roman L. Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. Am J Obstet Gynecol. 1999 Feb; 180(2 Pt 1):276-82. PMID: 9988787.
        View in: PubMed
      102. Miroshnikov BI, Roman L, Pavelets KV, Shostka KG, Burakov VV. [Lymph node dissection in esophageal cancer]. Vestn Khir Im I I Grek. 1999; 158(5):50-3. PMID: 10645582.
        View in: PubMed
      103. Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman L. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1998 Sep; 70(3):334-8. PMID: 9790784.
        View in: PubMed
      104. Roman L, Muderspach LI, Burnett AF, Morrow CP. Carcinoembryonic antigen in women with isolated pelvic masses. Clinical utility? J Reprod Med. 1998 May; 43(5):403-7. PMID: 9610461.
        View in: PubMed
      105. Roman L. Small cystic pelvic masses in older women: is surgical removal necessary? Gynecol Oncol. 1998 Apr; 69(1):1-2. PMID: 9570989.
        View in: PubMed
      106. Roman L, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 1998 Mar; 68(3):220-5. PMID: 9570969.
        View in: PubMed
      107. Duggan BD, Wan M, Yu MC, Roman L, Muderspach LI, Delgadillo E, Li WZ, Martin SE, Dubeau L. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. J Natl Cancer Inst. 1998 Feb 04; 90(3):238-42. PMID: 9462682.
        View in: PubMed
      108. Roman L, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol. 1997 Nov; 90(5):759-64. PMID: 9351760.
        View in: PubMed
      109. Muggia FM, Jeffers S, Muderspach L, Roman L, Rosales R, Groshen S, Safra T, Morrow CP. Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin). Gynecol Oncol. 1997 Aug; 66(2):290-4. PMID: 9264578.
        View in: PubMed
      110. Muderspach LI, Curtin JP, Roman L, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol. 1997 May; 65(2):336-42. PMID: 9159348.
        View in: PubMed
      111. Roman L, Muderspach LI, Stein SM, Laifer-Narin S, Groshen S, Morrow CP. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol. 1997 Apr; 89(4):493-500. PMID: 9083301.
        View in: PubMed
      112. Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang LJ. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol. 1997 Mar; 15(3):987-93. PMID: 9060537.
        View in: PubMed
      113. Roman L, Bogorodskii IP, Skriabin ON, Fedorov KA, Naumov EV. [Successful surgical treatment of cancer with multiple location]. Vopr Onkol. 1997; 43(2):230. PMID: 9214133.
        View in: PubMed
      114. Moyses HM, Morrow CP, Muderspach LI, Roman L, Vasilev SA, Petrovich Z, Groshen SL, Klement V. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol. 1996 Oct; 19(5):433-8. PMID: 8823468.
        View in: PubMed
      115. Shurkus VE, Roman L, Shurkus EA. [Variants in the definitive organization of the lumbar lymph-conducting pathways in the applied aspect]. Vestn Khir Im I I Grek. 1996; 155(6):49-53. PMID: 9163155.
        View in: PubMed
      116. Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, Kucera PR, Roman L. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol. 1995 Nov; 13(11):2752-6. PMID: 7595734.
        View in: PubMed
      117. Stein SM, Laifer-Narin S, Johnson MB, Roman L, Muderspach LI, Tyszka JM, Ralls PW. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. AJR Am J Roentgenol. 1995 Feb; 164(2):381-6. PMID: 7839975.
        View in: PubMed
      118. Kobak WH, Roman L, Felix JC, Muderspach LI, Schlaerth JB, Morrow CP. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet Gynecol. 1995 Feb; 85(2):197-201. PMID: 7824230.
        View in: PubMed
      119. Israel VK, Jiang C, Muggia FM, Tulpule A, Jeffers S, Leichman L, Morrow CP, Roman L, Leichman CG, Chan KK. Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study. Cancer Chemother Pharmacol. 1995; 37(1-2):32-8. PMID: 7497594.
        View in: PubMed
      120. Felix JC, Muderspach LI, Duggan BD, Roman L. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol. 1994 Dec; 84(6):996-1000. PMID: 7970484.
        View in: PubMed
      121. Uziely B, Groshen S, Jeffers S, Morris M, Russell C, Roman L, Muderspach L, Muggia F. Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications. Ann Oncol. 1994 Nov; 5(9):827-33. PMID: 7848885.
        View in: PubMed
      122. Zweizig S, Roman L, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol. 1994 Apr; 53(1):121-2. PMID: 8175010.
        View in: PubMed
      123. Duggan B, Muderspach LI, Roman L, Curtin JP, d'Ablaing G, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol. 1993 Oct; 82(4 Pt 1):598-602. PMID: 8377988.
        View in: PubMed
      124. Roman L, Morris M, Mitchell MF, Eifel PJ, Burke TW, Atkinson EN. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84. PMID: 8375732.
        View in: PubMed
      125. Roman L, Mitchell MF, Tornos C, Glover A, Kavanagh JJ. Dedifferentiated extrauterine adenosarcoma responsive to chemotherapy. Gynecol Oncol. 1993 Jun; 49(3):389-94. PMID: 8390963.
        View in: PubMed
      126. Roman L, Morris M, Eifel PJ, Burke TW, Gershenson DM, Wharton JT. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9. PMID: 1553163.
        View in: PubMed
      127. Hunter RE, Griffin TW, Stevens S, Roman L, Bokhari F, Reale FR, Tak WK, Fitzgerald TJ, Dillon MB, Rose PG. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer. Cancer. 1991 Nov 01; 68(9):1890-4. PMID: 1655227.
        View in: PubMed
      128. Roman L, Mitchell MF, Burke TW, Silva EG. Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5. PMID: 2050311.
        View in: PubMed
      129. Rose PG, Roman L, Reale FR, Tak WK, Hunter RE. Primary adenocarcinoma of the breast arising in the vulva. Obstet Gynecol. 1990 Sep; 76(3 Pt 2):537-9. PMID: 2199874.
        View in: PubMed